# Proliferation, migration, and differentiation of circulating ILC precursors in HBV infection-associated fibrosis

**Authors:** Qin Zhu, Fang-yuan Chen, Shi-qin Li, Cheng-zhao Weng, Si-qi Wang, Lin-lin Zheng, Yong-yu Yang, Li Xie, Jian Wu, Wei Jiang

PMC · DOI: 10.1186/s40001-025-03803-w · European Journal of Medical Research · 2026-01-05

## TL;DR

This study explores how innate lymphoid cell precursors behave in liver fibrosis caused by HBV infection, finding increased numbers and specific signaling pathways involved.

## Contribution

The study identifies the role of ILC precursors and their differentiation in HBV-associated fibrosis, highlighting IL-23 and Notch signaling.

## Key findings

- ILCPs and ILC3 subsets are enriched in PBMCs of CHB patients and HBV-transgenic mice.
- CD62L and CXCR6-expressing ILCPs are proportionally enriched in these conditions.
- IL-23 promotes ILCP recruitment and differentiation, while Notch signaling inhibition suppresses these processes.

## Abstract

Increased studies indicate that innate lymphoid cells (ILCs) are involved in inflammatory and immune responses in chronic liver injury. However, recruitment and maturation of their subsets during hepatic fibrosis post-HBV infection are unknown. The present study aims to explore the potential impact of ILC precursors (ILCPs) on the modulation of HBV infection-associated fibrosis.

Peripheral blood mononuclear cells (PBMCs) from healthy controls (HCs), chronic hepatitis B infected (CHB), and cirrhotic patients and lymphoid and splenic mononuclear cells from HBV-transgenic mice were isolated to determine the richness of ILC precursors (ILCPs) and ILC subsets by flow cytometry.

The richness of ILCPs and ILC3 subsets was significantly increased in PBMCs of patients with chronic hepatitis B infection and in lymph nodes and spleens of HBV-transgenic mice with carbon tetrachloride treatment. Importantly, among these ILCPs, the percentage of CD62L and CXCR6-expressing ILCPs were proportionally enriched. IL-23 may contribute to CD62L+ and CXCR6+ ILCP recruitment and differentiation into ILC3 subsets; whereas a Notch signaling inhibitor DAPT exerted inhibitory effects on them.

The microenvironment of HBV infection-associated fibrosis enhances the proliferation, migration, and differentiation of peripheral ILCPs and IIL-23, and Notch signaling pathways may play significant roles in these processes.

The online version contains supplementary material available at 10.1186/s40001-025-03803-w.

## Linked entities

- **Proteins:** IL37 (interleukin 37)
- **Chemicals:** carbon tetrachloride (PubChem CID 5943)
- **Diseases:** chronic hepatitis B (MONDO:0005344), cirrhosis (MONDO:0005155)

## Full-text entities

- **Genes:** SELL (selectin L) [NCBI Gene 6402] {aka CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL}, CXCR6 (C-X-C motif chemokine receptor 6) [NCBI Gene 10663] {aka BONZO, CD186, CDw186, STRL33, TYMSTR}, IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}
- **Diseases:** fibrosis (MESH:D005355), inflammatory (MESH:D007249), CHB (MESH:D019694), HBV infection (MESH:D006509), cirrhotic (MESH:D000094724), hepatic fibrosis (MESH:D008103), chronic liver injury (MESH:D056487)
- **Chemicals:** DAPT (-), carbon tetrachloride (MESH:D002251)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12870510/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12870510/full.md

---
Source: https://tomesphere.com/paper/PMC12870510